FDA approves new version of diabetes drug Mounjaro for weight loss

FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26, 2017. A new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight. A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

Touted by celebrities and on social media, semaglutide and tirzepatide drugs have already been in such demand that their manufacturers have struggled to keep up. Both have been listed on the FDA’s drug shortage site for months. All strengths of tirzepatide are currently listed as available, but a company spokesperson said that could vary by location and demand.

While experts lauded approval of Zepbound, they worried that it wouldn't necessarily mean greater access to the drug, which has been prescribed “off-label” to help people pare pounds. Eli Lilly and Co. said the list price for will be about $1,000 a month, the same as Mounjaro. Medicare is prohibited from covering drugs specifically for weight loss.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug
Source: KIRO7Seattle - 🏆 271. / 63 Read more »

FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds.
Source: AP - 🏆 728. / 51 Read more »

FDA approves new version of diabetes drug Mounjaro for weight lossA new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
Source: WashTimes - 🏆 235. / 63 Read more »

Eli Lilly’s Mounjaro Approved for Weight Loss in the U.S.The drug, which will be sold as Zepbound as an anti-obesity treatment, had previously been cleared by the FDA for the treatment of Type 2 diabetes
Source: WSJ - 🏆 98. / 63 Read more »